Who are Sana Biotechnology, Inc.'s main suppliers?

Sana Biotechnology, Inc. (SANA) key suppliers include: TD-SECURITIES-USA-LLC, Beam Therapeutics Inc., Beam Therapeutics Inc., CEROW, Myriad Genetics, Inc. and 3 more. View the full supplier network at chainsifter.com/chain/SANA.

Who are Sana Biotechnology, Inc.'s major customers?

Sana Biotechnology, Inc. (SANA) key customers include: MAYO-CLINIC, Beam Therapeutics Inc., Beam Therapeutics Inc., Myriad Genetics, Inc., Myriad Genetics, Inc. and 5 more. View the full customer network at chainsifter.com/chain/SANA.

What sector is Sana Biotechnology, Inc. in?

Sana Biotechnology, Inc. (SANA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Sana Biotechnology, Inc. Suppliers, Customers & Supply Chain (SANA)

8Suppliers

10Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Sana Biotechnology, Inc. (SANA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

21Total relationships

4Distinct source URLs

5High confidence

0.750Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Sana Biotechnology, Inc. Suppliers

Ticker	Name	Confidence	Evidence
TD-SECURITIES-USA-LLC	TD-SECURITIES-USA-LLC	90%	In March 2026, the Company entered into an amended and restated sales agreement with TD Securities (USA) LLC (TD Cowen), acting as sales agent, pursuant to which the Company may offer and sell throug…
BEAM	Beam Therapeutics Inc.	72%	Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: Reciprocal relationship from BEAM g…
BEAM	Beam Therapeutics Inc.	72%	the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licensed from Beam Therapeutics Inc., among ot…
CEROW	CEROW	72%	Reciprocal relationship from CEROW graph: y engineered T cells. Adoptively transferred T cells proliferate upon their engagement with target antigens and represent a form of therapy that can be appro…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from SANA graph: with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property,…
MYGN	Myriad Genetics, Inc.	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
SNYNF	Sanofi	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SANA graph: with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property…

Sana Biotechnology, Inc. Customers

Ticker	Name	Confidence	Evidence
MAYO-CLINIC	MAYO-CLINIC	92%	The Company agreed to sell to Mayo Clinic, and Mayo Clinic agreed to purchase from the Company, (i) 7,507,507 shares (the "Initial Shares") of the Company's common stock, $0.0001 par value per share …
BEAM	Beam Therapeutics Inc.	72%	Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: the University of California (UCSF)…
BEAM	Beam Therapeutics Inc.	72%	the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licensed from Beam Therapeutics Inc., among ot…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from SANA graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from SANA graph: Reciprocal relationship from MYGN g…
MYGN	Myriad Genetics, Inc.	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from SANA graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SANA graph: Reciprocal relationship from SNYN…
SNYNF	Sanofi	72%	with or controlled by state actors. If any theft or intrusion affects our technology, data, or intellectual property, the value of such technology, data, or intellectual property to our company may b…
CELLECT-LLC	CELLECT-LLC	62%	d to expend significant resources to modify and maintain our business practices in our efforts to comply with such laws and regulations and to otherwise ensure appropriate and lawful use of AI Techno…
COBALT-BIOMEDICINE-INC	COBALT-BIOMEDICINE-INC	62%	of the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licensed from Beam Therapeutics Inc., among…
USA-LLC	USA-LLC	62%	aintaining the Company’s intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Liquidity and capital resources The Company is subjec…

Sana Biotechnology, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SANA-DEBT	Debt stack $82.6M	90%	Market cache reports total debt of $82.6M.
SANA-DEBT-12365	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.

Sana Biotechnology, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Sana Biotechnology, Inc..

Sana Biotechnology, Inc. Ownership

Holder	Name	Confidence	Evidence
SANA-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 201 tracked holders.

Sana Biotechnology, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ATOS	Atossa Therapeutics, Inc.	100.00	2
CALC	CalciMedica, Inc.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2
EDIT	Editas Medicine, Inc.	100.00	2
CEROW	CERO THERAPEUTICS HOLDINGS, INC.	100.00	1	['supplier']
BNTC	Benitec Biopharma Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
BEAM	Beam Therapeutics Inc.	100.00	1	['customer', 'supplier']
CBIO	Crescent Biopharma, Inc.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2

Sana Biotechnology, Inc. Supply Chain